FDA Clears Use of Lilly’s COVID-19 Antibody Therapy for Kids

The U.S. Food and Drug Administration on Friday authorized the use of Eli Lilly’s COVID-19 dual-antibody therapy in treating mild to moderate symptoms in all children, including newborns, who are at risk of severe illness. Read More